Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PSN-GK1 is a potent activator of glucokinase (EC50: 0.13 μM).
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
25 mg | ¥ 10,600 | 6-8周 | ||
50 mg | ¥ 13,800 | 6-8周 | ||
100 mg | ¥ 17,500 | 6-8周 |
产品描述 | PSN-GK1 is a potent activator of glucokinase (EC50: 0.13 μM). |
体内活性 | PSN-GK1 exhibits an excellent pharmacokinetic profile, with high oral bioavailability, in the rat. PSN-GK1 can markedly reduce blood glucose which accompanied by a trend toward increased pancreatic insulin release. PSN-GK1 engenders potent antihyperglycemic effects in diabetic rodents without causing hypoglycemia [1]. At 5 mM glucose, PSN-GK1 activates glucokinase (4.3-fold, EC50: 130 nM), increases MIN6 insulin secretion (26-fold, EC50: 267 nM) and 2-DG hepatocytic uptake (3-fold, EC50: 1 μM). In C57Bl/6 mice, PSN-GK1 reduces blood glucose at 1 and 10 mg/kg (by mouth), but insulin is increased significantly at only the higher dose. In hyperinsulinaemic 10-mM glucose clamps, PSN-GK1 increases2-DG incorporation into liver glycogen sixfold [2]. |
分子量 | 438.54 |
分子式 | C20H23FN2O4S2 |
CAS No. | 745051-61-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
PSN-GK1 745051-61-0 Others PSNGK1 PSN GK1 PSN-GK-1 Inhibitor inhibitor inhibit